NASDAQ: RXRX · Biotechnology
Over the past week, Recursion Pharmaceuticals (RXRX) saw about 151 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 25% bullish across the tracked sources. Wall Street is more constructive, with 3 of 7 analysts rating RXRX a buy.
There is steady buzz around RXRX this week and broad agreement on direction, which is why it reads as a Sell.
Wall Street’s 43% buy share sits next to a crowd that ranges from News at 17% to Reddit at 33%. No other tracker puts the two side by side.
Across 7 analysts the consensus is a Hold: 3 buy calls against 0 sell, with an average 12-month price target of $7.22.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is cooling and the 3 sources only partly agree, so the read is a Sell.
Analysts sit 18 points above the crowd average of 25%, the professionals are more constructive than retail. The split is inside the crowd: Reddit reads 33% bullish while News sits at 17%, a 16-point spread that single-source trackers miss.
Over the 30-day window, Recursion Pharmaceuticals (RXRX) buzz held moderate around 49.1 while the price drifted up 36.3% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 28.8M shares. Updated Oct 10, 2026. Over the last 7 trading days, RXRX gained 7.1%. Buzz activity in the recent week averaged 42.3 and was relatively stable, swinging between 33.1 and 51.0. Recent volume is running above the 30-day average, suggesting heightened trading interest. Daily crowd sentiment leaned bullish on 18 of the 20 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for RXRX and 2110+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live RXRX sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Oct 10, 2026.
| Adanos signal | Sell |
|---|---|
| Analyst consensus | Hold (3 / 4 / 0) |
| Crowd bullish (7d) | 25% |
| Avg price target | $7.22 |
| Most bullish source | Reddit, 33% |
| Most bearish source | News, 17% |
| Sentiment spread | 16 pts |
| Mentions (7d) | 151 |
| Market cap | $2.12B |
| EPS · Beta | -$1.00 · 1.0 |
| Revenue (TTM) | $54.9M · 0% margin |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, Recursion Pharmaceuticals (RXRX) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 25% bullish across 3 active sources. Those sources contribute 151 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Recursion Pharmaceuticals (RXRX) is fairly quiet with 33 mentions over the last 7 days; the 30-day context spans 12 tracked subreddits. The 7-day tone is 33% bullish; 3-day activity momentum is falling, suggesting cooling attention.
The crowd reads bearish on Recursion Pharmaceuticals (RXRX), averaging 25% bullish across 3 tracked sources over the last 7 days. The two ends of the range are Reddit at 33% bullish and News at 17%, a 16-point spread. On the professional side, 3 of 7 analysts rate RXRX a buy.
Of the 7 analysts covering Recursion Pharmaceuticals (RXRX), 3 rate it a buy, 4 a hold and 0 a sell, for a hold consensus. The average price target is $7.22. That puts the street ahead of the crowd, which averages 25% bullish.
Recursion Pharmaceuticals (RXRX)'s cross-source average is bearish at 25% bullish. All 3 tracked sources lean bearish. Reddit reads 33% bullish, X reads 24% bullish and news coverage is the most negative at 17% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
The cross-source average is bearish for Recursion Pharmaceuticals (RXRX) at 25% bullish. All 3 tracked sources lean bearish. The most bearish reading is news at 17% bullish. 3-day activity momentum is falling on Reddit and X, while news activity is rising. The sell signal carries 93/100 conviction.
X is the dominant discussion channel with 106 mentions (70% of total volume). Reddit contributes 33 mentions and News contributes 12 mentions. The cross-source average is bearish at 25% bullish, while news is the only source with rising 3-day activity. All 3 tracked sources lean bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. RXRX's sell signal at 93/100 conviction reflects a bearish cross-source average at 25% bullish. All 3 tracked sources lean bearish. It is a research shortcut, not financial advice.
The RXRX sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Sell signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key